title: [Comparison of 2 antibiotic combinations used for peritonitis. Cefotaxime-clindamycin versus cefotaxime-metronidazole].
abstract: In this prospective and randomized trial involving 38 patients operated upon for generalized or localized peritonitis, 2 combinations of antibiotics were assessed on the basis of 5 predetermined criteria: number of successes and failures, duration of fever, leucocytosis, antibiotic therapy and stay in hospital. No significant difference was observed between the two therapeutic groups. The spectrum of sensitive organisms and the effectiveness of treatment could be considered satisfactory whatever the combination utilized. The 86.8 percent clinical success rate suggests that the cefotaxime-clindamycin combination should be used more frequently than it is now.
authors.affiliation: Service d'Urgence chirurgicale viscérale, hôpital Edouard-Herriot, Lyon.
authors.forename: X
authors.initials: X
authors.lastname: Barth
authors.forename: H
authors.initials: H
authors.lastname: Hayoun
authors.forename: P
authors.initials: P
authors.lastname: Rat
authors.forename: J P
authors.initials: JP
authors.lastname: Hoen
authors.forename: J P
authors.initials: JP
authors.lastname: Favre
authors.forename: R
authors.initials: R
authors.lastname: Lombard-Platet
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002439:Cefotaxime / Q000627:therapeutic use*; D002981:Clindamycin / Q000627:therapeutic use*; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008795:Metronidazole / Q000627:therapeutic use*; D008875:Middle Aged; D010538:Peritonitis / Q000188:drug therapy* / Q000601:surgery; D011183:Postoperative Complications; D011446:Prospective Studies; D016032:Randomized Controlled Trials as Topic
chemical_list: D008795:Metronidazole; D002981:Clindamycin; D002439:Cefotaxime
vernacular_title: Comparaison de deux associations d'antibiotiques au cours des péritonites. céfotaxime + clindamycine versus céfotaxime + métronidazole.